Nancy E. Dempze’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-475
| Closed | -$263K | – | 105 |
|
|
2024
Q2 | $263K | Buy |
475
+20
| +4% | +$11.1K | 0.18% | 69 |
|
|
2024
Q1 | $264K | Sell |
455
-6
| -1% | -$3.49K | 0.2% | 55 |
|
|
2023
Q4 | $245K | Hold |
461
| – | – | 0.2% | 52 |
|
|
2023
Q3 | $233K | Sell |
461
-61
| -12% | -$30.9K | 0.21% | 58 |
|
|
2023
Q2 | $272K | Hold |
522
| – | – | 0.23% | 57 |
|
|
2023
Q1 | $301K | Sell |
522
-4
| -0.8% | -$2.31K | 0.27% | 53 |
|
|
2022
Q4 | $290K | Buy |
526
+25
| +5% | +$13.8K | 0.28% | 54 |
|
|
2022
Q3 | $254K | Hold |
501
| – | – | 0.27% | 55 |
|
|
2022
Q2 | $272K | Hold |
501
| – | – | 0.27% | 58 |
|
|
2022
Q1 | $296K | Hold |
501
| – | – | 0.22% | 68 |
|
|
2021
Q4 | $334K | Sell |
501
-10
| -2% | -$6.67K | 0.23% | 66 |
|
|
2021
Q3 | $292K | Sell |
511
-5
| -1% | -$2.86K | 0.23% | 65 |
|
|
2021
Q2 | $261K | Buy |
516
+51
| +11% | +$25.8K | 0.22% | 62 |
|
|
2021
Q1 | $213K | Sell |
465
-10
| -2% | -$4.58K | 0.19% | 66 |
|
|
2020
Q4 | $221K | Hold |
475
| – | – | 0.2% | 63 |
|
|
2020
Q3 | $210K | Buy |
+475
| New | +$210K | 0.21% | 65 |
|